Download Files:
Rovazolac
SKU
HY-109073-10 mg
Category Reference compound
Tags Inflammation/Immunology, LXR, Metabolic Enzyme/Protease;Vitamin D Related/Nuclear Receptor
$350 – $2,650
Products Details
Product Description
– Rovazolac is a liver x receptor (LXR) modulator extracted from patent WO2013130892A1.
Web ID
– HY-109073
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C21H19F3N2O4S
References
– [1]Mohan R. Preparation of substituted pyrazoles as liver X receptor (LXR) modulators useful for the treatment of dermal diseases, disorders and conditions. WO2013130892A1
CAS Number
– 1454288-88-0
Molecular Weight
– 452.45
Compound Purity
– 99.68
SMILES
– O=C(OCC)CN1C(C2=CC=C(C3=CC(S(C)(=O)=O)=CC=C3)C=C2)=CC(C(F)(F)F)=N1
Clinical Information
– No Development Reported
Research Area
– Inflammation/Immunology
Solubility
– Ethanol : 10 mg/mL (ultrasonic)
Target
– LXR
Pathway
– Metabolic Enzyme/Protease;Vitamin D Related/Nuclear Receptor
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.